EA201300672A1 - Шоколадная масса - Google Patents

Шоколадная масса

Info

Publication number
EA201300672A1
EA201300672A1 EA201300672A EA201300672A EA201300672A1 EA 201300672 A1 EA201300672 A1 EA 201300672A1 EA 201300672 A EA201300672 A EA 201300672A EA 201300672 A EA201300672 A EA 201300672A EA 201300672 A1 EA201300672 A1 EA 201300672A1
Authority
EA
Eurasian Patent Office
Prior art keywords
chocolate mass
content
tocotrienols
tocopherols
chocolate
Prior art date
Application number
EA201300672A
Other languages
English (en)
Other versions
EA023842B1 (ru
Inventor
Йоханнес Кой
Original Assignee
Мд&Д Альянс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мд&Д Альянс Гмбх filed Critical Мд&Д Альянс Гмбх
Publication of EA201300672A1 publication Critical patent/EA201300672A1/ru
Publication of EA023842B1 publication Critical patent/EA023842B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/40—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/608—Galactose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/62—Palatinose, isomaltulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/634—Tagatose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/636—Trehalose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/712—Vitamin E

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предлагается новый вид шоколадной массы, гликемический индекс (GI) которой составляет ниже 29 (GI<29), содержание добавленных сахаров в которой включает по меньшей мере 10% галактозы и которая дополнительно содержит изомальтулозу и/или тагатозу. Помимо этого, шоколадная масса содержит витамин Е в виде смеси токотриенолов-токоферолов из природных источников, причём содержание токотриенолов в шоколадной массе превышает содержание токоферолов.
EA201300672A 2011-01-06 2011-12-15 Шоколадная масса и её применение EA023842B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011008016A DE102011008016A1 (de) 2011-01-06 2011-01-06 Schokoladenmasse
PCT/DE2011/002131 WO2012092916A1 (de) 2011-01-06 2011-12-15 Schokoladenmasse

Publications (2)

Publication Number Publication Date
EA201300672A1 true EA201300672A1 (ru) 2013-12-30
EA023842B1 EA023842B1 (ru) 2016-07-29

Family

ID=46025274

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300672A EA023842B1 (ru) 2011-01-06 2011-12-15 Шоколадная масса и её применение

Country Status (16)

Country Link
US (1) US10694761B2 (ru)
EP (1) EP2590514B1 (ru)
CN (1) CN103491796B (ru)
BR (1) BR112013017370B1 (ru)
CL (1) CL2013001989A1 (ru)
CO (1) CO6761363A2 (ru)
DE (1) DE102011008016A1 (ru)
EA (1) EA023842B1 (ru)
ES (1) ES2517465T3 (ru)
MX (1) MX2013007882A (ru)
PE (1) PE20140499A1 (ru)
PL (1) PL2590514T3 (ru)
SG (1) SG191405A1 (ru)
UA (1) UA91011U (ru)
WO (1) WO2012092916A1 (ru)
ZA (1) ZA201304348B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012017884A1 (de) * 2012-08-03 2014-02-20 Krüger Gmbh & Co. Kg Zusammensetzung für die retardierte Resorption
JP6499585B2 (ja) * 2012-11-29 2019-04-10 ネステク ソシエテ アノニム 低血糖指数を有する炭水化物によるフラバン−３−オールのバイオアベイラビリティの増大
WO2014159500A1 (en) * 2013-03-14 2014-10-02 University Of Florida Research Foundation, Incorporated Regulation of cancer using natural compounds and/or diet
JP2017513953A (ja) * 2014-04-25 2017-06-01 ネキシラ インターナショナル 腸内不浸透性を改善するためのアラビアゴム（ａｇ）を含む組成物の利用
CH710346A1 (it) * 2014-11-07 2016-05-13 Tassone Agostino Composizione nutraceutica di alimenti.
US11020372B2 (en) 2015-03-24 2021-06-01 University Of Florida Research Foundation, Incorporated Dietary and natural product management of negative side effects of cancer treatment
RU2620636C2 (ru) * 2015-07-06 2017-05-29 Валерий Анатольевич Алиев Состав для приготовления мягкого шоколада и способ приготовления мягкого шоколада из этого состава
CN105594949A (zh) * 2015-12-21 2016-05-25 长春大学 一种添加天然植物性类雌激素的巧克力及生产方法
EP3537885A1 (en) 2016-11-10 2019-09-18 Immd SP. Zo.o Functional chocolate
CN107410626A (zh) * 2017-04-14 2017-12-01 安徽兆龙食品有限公司 一种含有茶多酚的巧克力及其制备方法
IT201800009489A1 (it) * 2018-10-16 2020-04-16 Ens Srl - European Nutritional Supplements Srl Matrice di cioccolato comprendente curcumina e resveratrolo
CN111436514A (zh) * 2020-03-06 2020-07-24 华南农业大学 一种肉桂精油生巧克力及其制备方法
RU2752921C1 (ru) * 2020-11-16 2021-08-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный технологический университет" (ФГБОУ ВО "КубГТУ") Шоколадная масса для получения шоколада специализированного назначения
IT202100021053A1 (it) * 2021-08-04 2023-02-04 Noi Nora Damonti Crema dolce ad uso alimentare
EP4298916A1 (en) * 2022-06-28 2024-01-03 Volodymyr Mandrin Chocolate product

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE381799B (sv) * 1972-08-18 1975-12-22 Semper Ab Forfarande for framstellning av s.k. "crumb" for tillverkning av mjolkchoklad
EP0247071B1 (en) * 1985-10-31 1993-09-22 The Australian National University Immunotherapeutic treatment
JPH05339148A (ja) * 1992-05-28 1993-12-21 T Knight Albert 血液脳関門を通過する物質
AU6165894A (en) * 1993-01-28 1994-08-15 Trustees Of The University Of Pennsylvania, The Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
WO1996014063A1 (en) * 1994-11-08 1996-05-17 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
ES2235499T3 (es) * 1998-07-30 2005-07-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena.
JP2001192342A (ja) * 2000-01-07 2001-07-17 Ta Stevia Co Ltd ステビア濃縮液剤および成熟ざくろ混合物の製造方法
US6608103B2 (en) * 2001-02-08 2003-08-19 Fuji Chemical Industry Co., Ltd. Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
US6416797B1 (en) * 2001-02-14 2002-07-09 Kraft Foods Holdings, Inc. Process for making a wheyless cream cheese using transglutaminase
US20040044028A1 (en) * 2001-03-30 2004-03-04 Obukowicz Mark G. Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancer
US6572901B2 (en) * 2001-05-02 2003-06-03 Kraft Foods Holdings, Inc. Process for making a cheese product using transglutaminase
US20030119879A1 (en) * 2001-10-15 2003-06-26 Thomas Landh Nicotine and chocolate compositions
JP3643932B2 (ja) * 2001-10-31 2005-04-27 味の素株式会社 チーズカードの製造方法
US8529956B2 (en) * 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
TWI337868B (en) * 2004-05-21 2011-03-01 Tzu Chi Buddhist General Hospital Method for extracting extract from chaenomeles lagenaria and the applications thereof
US8435576B2 (en) * 2005-01-28 2013-05-07 Barry Callebaut Ag Use of cocoa polyphenols for treating a prostate hyperplasia, a specific cocoa extract and applications
EP1701165A1 (en) * 2005-03-07 2006-09-13 Johannes Dr. Coy Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
PL2256500T3 (pl) 2005-03-07 2014-10-31 Coy Dr Johannes F Zastosowanie inhibitorów enzymu TKTL1
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
CN101263391A (zh) * 2005-09-12 2008-09-10 菲诺梅诺米发现公司 通过测量维生素e-相关的代谢物诊断结肠直肠癌和卵巢癌的方法
US20090306198A1 (en) * 2005-09-16 2009-12-10 Robert Nicolosi Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner
ES2706281T3 (es) * 2005-12-20 2019-03-28 Nutricia Nv Composición de carbohidratos y respuesta disminuida de glucosa
KR20080078073A (ko) * 2005-12-24 2008-08-26 디에스엠 아이피 어셋츠 비.브이. 장시간 동안의 체중 유지
JP2009530305A (ja) * 2006-03-17 2009-08-27 ハーバルサイエンス シンガポール ピーティーイー． リミテッド ウコン種を含む抽出物および方法
DE102006014543A1 (de) 2006-03-21 2007-09-27 Südzucker AG Mannheim/Ochsenfurt Funktionelle Lebensmittel gegen Tumore
US7879370B2 (en) * 2006-04-26 2011-02-01 Merican Corporation Composition of which chief ingredient is polysaccharides having an immunoregulatory function
CN101077356B (zh) * 2006-05-24 2010-12-01 上海中医药大学 一种蜈蚣藻多糖提取物在制备抗肿瘤药物中的应用
US8017147B2 (en) * 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
AU2008205325B2 (en) * 2007-01-10 2013-09-12 Dsm Nutritional Products Ag Vegetarian microcapsules
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
EP1982601A1 (en) * 2007-04-17 2008-10-22 Nestec S.A. Reduced sugar ice confection
US20080260925A1 (en) 2007-04-23 2008-10-23 Galen Paul Zink Means for replacing common sugars if foods for enhanced nutrition
MY162051A (en) * 2007-05-24 2017-05-31 Loders Croklaan Bv Process for producing compositions comprising tocopherols and tocotrienols
WO2009051609A1 (en) * 2007-10-19 2009-04-23 Pardee Joel D Metabolic enhancement therapy
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
JP5358952B2 (ja) * 2008-01-10 2013-12-04 和光純薬工業株式会社 膵臓癌マーカーおよび膵臓癌の検査方法
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
WO2009151394A1 (en) * 2008-06-11 2009-12-17 Astrazeneca Ab Sublingual compositions comprising (2s) - (4e) -n-methyl-5- (3- (5-isopropoxypyridin) yl) -4-penten-2-amine
CN101422439A (zh) * 2008-11-14 2009-05-06 李铁军 一种注射用依托泊苷冻干粉针制剂及其制备方法
US20110306579A1 (en) * 2009-01-30 2011-12-15 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
CN101822808A (zh) * 2009-03-02 2010-09-08 高汉卿 一种用中草药热敷治疗肿瘤的外用药物
WO2010104374A1 (en) * 2009-03-09 2010-09-16 N.V. Nutricia Nutritional composition inducing a postprandial endocrine response
PL2413717T3 (pl) * 2009-04-01 2014-11-28 Montero Gida Sanayi Ve Ticaret As Kompozycje dietetycznej czekolady i sposób ich wytwarzania
US20130136800A1 (en) * 2010-03-31 2013-05-30 Vegenat, S.A. Enteral Or Oral Food Product Intended, In Particular, For nutrition And For The Prevention And Improvement Of Neurological Alterations, Neurodegenerative Alterations or Cognitive Disorders

Also Published As

Publication number Publication date
PL2590514T3 (pl) 2015-02-27
UA91011U (ru) 2014-06-25
EA023842B1 (ru) 2016-07-29
EP2590514B1 (de) 2014-08-06
ZA201304348B (en) 2014-02-26
EP2590514A1 (de) 2013-05-15
CN103491796A (zh) 2014-01-01
MX2013007882A (es) 2013-11-20
BR112013017370A2 (pt) 2017-10-17
WO2012092916A1 (de) 2012-07-12
CL2013001989A1 (es) 2014-02-07
DE102011008016A1 (de) 2012-07-12
ES2517465T3 (es) 2014-11-03
US20130280357A1 (en) 2013-10-24
PE20140499A1 (es) 2014-05-15
US10694761B2 (en) 2020-06-30
CN103491796B (zh) 2014-10-08
SG191405A1 (en) 2013-08-30
CO6761363A2 (es) 2013-09-30
BR112013017370B1 (pt) 2018-07-17

Similar Documents

Publication Publication Date Title
EA201300672A1 (ru) Шоколадная масса
AU2018253580A1 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
EP4036240A3 (en) Transduction buffer
EA202190619A1 (ru) Противовирусные соединения
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
BR112014030903A2 (pt) máquina de bebida com inibidor de vibração
EA201790781A3 (ru) Противовирусные соединения
BR112014029754A2 (pt) soluções de tensoativos contendo n-metil-n-oleilglucaminas e n-metil-n-c12-c14-acilglucaminas
EA201490420A1 (ru) ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С α-СУБЪЕДИНИЦАМИ ПОТЕНЦИАЛЗАВИСИМЫХ НАТРИЕВЫХ КАНАЛОВ (SCNxA), С ПОМОЩЬЮ МАЛЫХ МОЛЕКУЛ
CO6761400A2 (es) Combinación de análogos de glucagón acilados con análogos de insulina
EA201071058A1 (ru) Получение леналидомида
EA201490854A1 (ru) Противовирусные соединения
EA201492002A1 (ru) Противовирусные соединения
ECSP088854A (es) Moduladores bencimidazolicos de vr1
EA201590854A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
BR112016008352A2 (pt) processo para a produção de polibutadienos catalisados com neodímio (ndbr), misturas de borracha que contêm polibutadienos catalisados com neodímio (ndbr), e usos de misturas de borracha
EA201070689A1 (ru) Композиция для личного ухода
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
MX2009009952A (es) Sal clorhidrato de 5-[3-(3-hidroxifenoxi)azetidin-1-il]-5-metil-2, 2-difenilhexanamida.
GEP20186911B (en) Substituted chroman compounds as calcium sensing receptor modulators
MX2016007436A (es) Composiciones para el cuidado oral que comprenden carbonato de calcio y talco.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
MX2010000979A (es) Metodos y composiciones para tratar enfermedad autoinmune.
WO2010072705A3 (de) TRANSPARENTE SCHWEIßHEMMENDE GELE
BR112012028559A2 (pt) composições biocidas, e, uso de ésteres de oligoglicerol alcoxilados